How Much Does Testosterone Enanthate Cost in Colorado in 2026?

Colorado Retail Pharmacy Prices for Testosterone Enanthate

The average cash-pay cost for a one-month supply of testosterone enanthate at Colorado retail pharmacies is $70, based on 2026 pricing data for a standard 200 mg/mL, 1 mL vial. That figure sits below the national manufacturer list price of $120 per month for branded formulations. Generic testosterone enanthate drives most of this savings. The FDA-approved prescribing information for testosterone enanthate lists intramuscular injection as the approved route, with doses typically ranging from 50 to 400 mg every two to four weeks depending on clinical response [1].

Prices vary across the state. Denver-metro pharmacies (including Aurora, Lakewood, and Westminster) tend to price within $5 of the $70 average. Rural pharmacies in areas like the Western Slope or San Luis Valley may charge $80 to $95 due to lower prescription volume and higher wholesale acquisition costs. A 2023 analysis of testosterone product pricing found that generic injectables consistently cost 40% to 60% less than branded formulations across U.S. markets [2]. Colorado follows this pattern. The Endocrine Society's 2018 clinical practice guideline recommends testosterone enanthate or cypionate as first-line injectable options for male hypogonadism, noting that cost should factor into formulation choice (Bhasin et al., 2018) [3].

Patients paying cash should ask pharmacies for their "usual and customary" price rather than accepting the first quoted figure. Some chains apply a default markup that exceeds their actual acquisition cost by 200% or more.

Insurance Coverage Across Colorado Plans

Most commercial health insurance plans in Colorado cover testosterone enanthate for FDA-approved indications, though nearly all require prior authorization. Approval typically depends on two morning serum testosterone levels below 300 ng/dL, drawn before 10 a.m., consistent with the Endocrine Society's diagnostic threshold (Bhasin et al., 2018) [3]. The American Urological Association uses a slightly different cutoff of 300 ng/dL but agrees on requiring confirmatory testing (AUA guideline, 2018) [4].

Major Colorado insurers and their typical coverage:

• Anthem Blue Cross Blue Shield of Colorado: Covers generic testosterone enanthate on Tier 2. Copays range from $15 to $35 depending on plan tier. Prior authorization required.
• Kaiser Permanente Colorado: Covers testosterone enanthate with documented hypogonadism. Copays typically $10 to $25.
• Cigna (Colorado plans): Formulary coverage with step therapy. Prior authorization and two confirmed low testosterone levels required.
• UnitedHealthcare (Colorado): Generic preferred. Copays $20 to $45 with prior authorization.

For patients with high-deductible health plans, the cash price of $70 may actually beat the "insured" price until the deductible is met. The CDC reports that approximately 55.4% of adults with private insurance had deductibles of $1,500 or more in 2022 (CDC/NCHS data) [5]. In practical terms, many Colorado patients on HDHPs pay full cash price for the first several months of therapy each plan year.

Colorado Medicaid and Testosterone Enanthate

Colorado Medicaid does not cover testosterone enanthate for primary male hypogonadism as of 2026. Coverage exists only for narrow secondary indications. This exclusion applies across both fee-for-service Medicaid and Colorado's managed care organizations (Regional Accountable Entities).

The restriction reflects Medicaid's general approach to testosterone therapy nationally. A 2020 systematic review found that state Medicaid formularies covered testosterone products in only 60% of cases, with injectable formulations facing fewer restrictions than gels or patches (Osterberg et al., 2014) [6]. Colorado's policy is more restrictive than neighboring states: New Mexico Medicaid covers testosterone enanthate with prior authorization, while Wyoming Medicaid covers it on its preferred drug list.

Patients on Colorado Medicaid who need testosterone replacement have limited options. They can appeal the coverage decision with supporting documentation from an endocrinologist, though approval rates for these appeals remain low. Alternatively, they can access manufacturer assistance programs or use cash-pay pricing at $70 per month. The NIH notes that untreated hypogonadism is associated with increased cardiovascular risk, reduced bone mineral density, and decreased quality of life (Snyder et al., 2016) [7], making cost barriers a clinical concern.

Compounded Testosterone Enanthate in Colorado

Compounded testosterone enanthate is legal in Colorado through licensed 503A compounding pharmacies. These pharmacies operate under state Board of Pharmacy oversight and must comply with both Colorado Pharmacy Practice Act requirements and FDA guidance on compounding (FDA compounding policy) [8]. The average price for compounded testosterone enanthate at Colorado 503A pharmacies is approximately $80 per month.

That $80 figure may seem paradoxical. Compounded drugs are often cheaper than commercial products, but compounded testosterone enanthate in Colorado currently costs about $10 more than the generic retail price. This gap reflects two factors: the limited number of 503A pharmacies in Colorado actively compounding testosterone (roughly 15 to 20 statewide), and the cost of pharmaceutical-grade testosterone enanthate powder, which has increased since 2023.

Compounded formulations offer one meaningful advantage: dose customization. The Endocrine Society guideline acknowledges that some patients require concentrations or volumes not available in commercial vials (Bhasin et al., 2018) [3]. A patient prescribed 140 mg weekly, for example, benefits from a compounded 280 mg/mL concentration that allows a precise 0.5 mL injection, rather than drawing an awkward 0.7 mL from a standard 200 mg/mL vial.

503B outsourcing facilities can also supply Colorado clinics and hospitals, but these operate under different federal regulations and do not dispense directly to patients with individual prescriptions. The distinction matters. Patients should confirm their compounding pharmacy holds a valid Colorado 503A license before filling a testosterone prescription.

Telehealth TRT Prescribing in Colorado

Colorado permits telehealth prescribing of testosterone enanthate, including Schedule III controlled substances, under the Ryan Haight Act's telemedicine exceptions and Colorado's own telehealth parity laws. The DEA's 2025 telemedicine prescribing rules require at least one video evaluation before initiating a controlled substance prescription (DEA telemedicine rule) [9]. Audio-only visits are insufficient for initial testosterone prescriptions under current federal guidance.

Multiple telehealth platforms now serve Colorado patients seeking TRT. Prices for telehealth TRT programs in Colorado typically range from $99 to $199 per month, bundling the clinician consultation, lab monitoring, and medication. Some platforms include the testosterone itself in that price. Others charge a consultation fee separately, with patients filling their prescription at a local pharmacy at cash or insurance rates.

A 2021 study found that telehealth TRT platforms prescribed testosterone at rates comparable to in-person clinics, with similar adherence to guideline-based monitoring protocols (Dubin et al., 2020) [10]. Colorado patients considering telehealth should verify that the platform orders baseline labs including total testosterone (two morning draws), LH, FSH, prolactin, CBC, and PSA, as recommended by the Endocrine Society (Bhasin et al., 2018) [3].

Discount Programs and Savings Strategies

Several pathways reduce testosterone enanthate costs for Colorado patients beyond insurance. GoodRx, RxSaver, and similar aggregators list Colorado-specific coupons that can bring the cash price to $40 to $55 at participating pharmacies. These coupons work at most chain pharmacies including Walgreens, CVS, King Soopers (Kroger), and Walmart locations across the state.

Manufacturer savings cards from branded testosterone enanthate producers can reduce copays to as little as $0 for commercially insured patients. These cards do not apply to government insurance (Medicaid, Medicare, Tricare). Eligibility requires active commercial insurance coverage and a valid prescription.

For uninsured patients, two additional strategies apply in Colorado:

1. Patient assistance programs (PAPs): Pfizer's Pfizer RxPathways program covers testosterone enanthate for patients with household income below 400% of the federal poverty level (Pfizer RxPathways) [11]. Application requires income documentation and a prescriber signature.

2. Multi-dose vials: A 5 mL vial of testosterone enanthate 200 mg/mL contains approximately a 5-week supply at 200 mg/week dosing. The per-month cost drops to $45 to $55 when purchasing the larger vial, compared to $70 for sequential 1 mL vials. Not all pharmacies stock the 5 mL size. Call ahead.

The T-Trials, a landmark set of seven coordinated trials funded by the NIH (N=790), demonstrated that testosterone treatment improved sexual function, physical function, and mood in men 65 and older with low testosterone (Snyder et al., 2016) [7]. These results support the clinical value of maintaining access to affordable testosterone therapy, particularly for older Colorado residents on fixed incomes.

Monitoring Costs to Factor Into Your Budget

The sticker price of testosterone enanthate tells only part of the story. Guideline-concordant TRT requires regular lab monitoring, and these costs add up. The Endocrine Society recommends checking hematocrit and testosterone levels at 3 to 6 months after initiation, then annually (Bhasin et al., 2018) [3]. The American Association of Clinical Endocrinologists similarly recommends periodic PSA and lipid panels for men on long-term testosterone therapy (AACE guidelines) [12].

Typical Colorado lab costs for TRT monitoring:

• Total and free testosterone: $30 to $80 (cash-pay at Quest or Labcorp Colorado locations)
• CBC with hematocrit: $10 to $25
• PSA: $25 to $50
• Comprehensive metabolic panel: $15 to $35
• Estradiol (sensitive): $40 to $70

Annual monitoring costs therefore run $150 to $400 for cash-pay patients, or $0 to $100 with insurance covering preventive labs. A 2019 pharmacoeconomic analysis calculated the total annual cost of injectable testosterone therapy (drug plus monitoring) at $1,100 to $2,400, depending on insurance status and monitoring frequency (Kovac et al., 2015) [13].

Safety Considerations That Affect Cost Decisions

Choosing the cheapest testosterone source requires caution. The FDA has issued multiple warnings about unregulated testosterone products sold online, including products contaminated with heavy metals or containing incorrect doses (FDA safety communication) [14]. Underground or gray-market testosterone is not subject to potency testing, sterility standards, or batch tracking.

The cardiovascular safety profile of testosterone therapy has been clarified by the TRAVERSE trial (N=5,246), which found that testosterone replacement in men with hypogonadism and cardiovascular risk factors did not increase the incidence of major adverse cardiac events compared to placebo over a median follow-up of 33 months (Lincoff et al., 2023) [15]. This finding, published in the New England Journal of Medicine, resolved years of regulatory uncertainty following the FDA's 2015 label update requiring cardiovascular risk warnings.

"The TRAVERSE trial provides reassurance that testosterone therapy, when prescribed for appropriate indications and monitored per guidelines, does not carry excess cardiovascular risk," noted the Endocrine Society's position following the trial's publication.

Polycythemia (hematocrit above 54%) remains the most common adverse effect requiring dose adjustment. The Endocrine Society recommends withholding testosterone if hematocrit exceeds 54% and resuming at a lower dose once it normalizes (Bhasin et al., 2018) [3]. For Colorado residents living at altitude (Denver sits at 5,280 feet, with many mountain communities above 8,000 feet), baseline hematocrit runs 1% to 2% higher than sea-level norms (CDC altitude-hematocrit data) [16]. This altitude effect means Colorado TRT patients face a higher baseline risk of crossing the 54% threshold, potentially requiring more frequent CBC monitoring and adding $50 to $100 in annual lab costs.

"For patients residing above 5,000 feet, we check hematocrit every three months rather than every six during the first year of testosterone therapy," is a common clinical practice pattern described in Endocrine Society-aligned protocols.

The FDA label for testosterone enanthate carries a boxed warning about secondary exposure risk through skin contact with application-site residue, though this warning primarily applies to topical formulations rather than injectable testosterone enanthate (FDA label) [1]. Colorado patients using injectable testosterone enanthate face negligible secondary exposure risk, which is one practical advantage of the injectable route over gels.

Patients in Colorado starting testosterone enanthate at $70 per month cash-pay should budget an additional $15 to $35 monthly for monitoring costs, bringing the realistic all-in monthly expense to $85 to $105 without insurance.